- Health Topics
- Health Education
- Research
- Grants and Training
- News and Events
- About NHLBI
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
WHAT: NHLBI-funded researchers have discovered a novel means by which viruses spread between cells: multiple polioviruses, a type of enterovirus, travel together within a membrane-enclosed sac, arriving together at a cell they then infect. This finding revises a central tenet of virology that viruses behave as independent infectious agents. The discovery also suggests that this infection pathway may operate in other enteroviruses, which are responsible for a number of diseases, such as myocarditis (heart inflammation), the common cold, and the respiratory illness caused by Enterovirus D68.
Led by Dr. Nihal Altan-Bonnet, the Earl Stadtman Investigator in the NHLBI’s Laboratory of Host-Pathogen Dynamics, the team of NHLBI-funded researchers published their findings in the journal Cell.
In their article, the researchers describe the practical consequences of this infection pathway and suggest possible aspects of it that scientists could target to limit infections. By arriving at an uninfected cell together, the viruses infect the cell more efficiently than lone viruses. Moreover, once inside the cell, the viruses delivered all together are better able to survive and reproduce than viruses operating independently. After reproducing in the cell, multiple viral particles become enclosed by a membrane derived from the cell and exit the cell without bursting the cell. Although the membrane enclosing the viral particles likely protects them from detection by the body’s immune system, the researchers found that the membrane contains particular fat molecules that drugs can block. These drugs prevented the viral clusters from infecting cultured cells. Further study of the cellular components involved in loading up the viral cargo into the membrane-bound sacs may reveal other potential approaches to stopping viral transmission between cells.
WHO: Nihal Altan-Bonnet, Ph.D., Earl Stadtman Investigator, Head of the NHLBI Laboratory of Host-Pathogen Dynamics, is available to comment on the findings and implications of this research.
CONTACT: For more information or to schedule an interview, please contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov.
Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at http://www.nhlbi.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.